Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025
Integra LifeSciences (Nasdaq: IART) will release third quarter 2025 financial results on Thursday, October 30, 2025, prior to market open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Integra LifeSciences (Nasdaq: IART) will release third quarter 2025 financial results on Thursday, October 30, 2025, prior to market open. Management will host a conference call the same day at 8:30 a.m. ET.
A live webcast will be available on the company Investors website at investor.integralife.com. Participants may register to receive dial-in details and an individual PIN; joining 10 minutes early is recommended. A webcast replay will be posted on the Investors website after the call.
Details
News Market Reaction – IART
On Oct 15, the day this news came out, IART closed 1.18% below the previous close.
Data tracked by StockTitan Argus for the Oct 15 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, will release third quarter 2025 financial results on Thursday, October 30, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.
A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.
About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.